AI Article Synopsis
- A 40-year-old woman had a right breast mass for a year, which grew larger, leading to a diagnosis of Stage ⅢC triple-negative breast cancer.
- She received 4 courses of EC therapy followed by 7 courses of paclitaxel plus bevacizumab before being referred for surgical intervention.
- After a successful right mastectomy and related surgeries, she experienced a good recovery and improved quality of life, indicating the effectiveness of the combined treatment approach for her condition.
Article Abstract
The case was a 40-year-old female who was aware of a right breast mass for 1 year before her first visit. She had visited her previous doctor because the mass was gradually increasing in size. After close examination, she was diagnosed with Stage ⅢC triple-negative breast cancer. She underwent 4 courses of EC therapy and 7 courses of paclitaxel(PTX)plus bevacizumab( Bev)therapy and was then, referred to our hospital for resection. We instituted a 2-month break from Bev to prevent postoperative complications. She underwent a right mastectomy, combined chest wall resection, lymph node dissection, and chest wall reconstruction. Because the postoperative course was good and quality of life improved, the multidisciplinary treatment with surgery and pharmacotherapy was considered effective in locally advanced breast cancer.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!